Coronary Artery Perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study

Thomas J Ford1,2,3, Carly Adamson1,2, Andrew J Morrow1,2

  • 1West of Scotland Heart and Lung Centre Golden Jubilee National Hospital Clydebank UK.

Insights

Coronary artery perforations during percutaneous coronary intervention increased from 2001-2019. Severe perforations led to worse outcomes, while early covered stents showed a high risk of stent thrombosis.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Coronary artery perforation is a rare but serious complication of percutaneous coronary intervention (PCI).
  • Understanding temporal trends and outcomes of PCI-related perforations is crucial for improving patient care.
  • Covered stents are used to manage complex coronary perforations, but their long-term outcomes require evaluation.

Purpose of the Study:

  • To report the incidence and outcomes of coronary artery perforations over an 18-year period.
  • To analyze temporal trends in coronary perforation incidence.
  • To evaluate the long-term outcomes of covered stent deployment for coronary perforations.

Main Methods:

  • Retrospective analysis of 43,343 consecutive PCI procedures from 2001-2019.
  • Classification of coronary perforations using the Ellis grading system.
  • Assessment of procedural and long-term clinical outcomes, including major adverse cardiac events and stent thrombosis.

Main Results:

  • The incidence of coronary perforation increased significantly over the study period (0.37% overall).
  • Severe perforations (Ellis grade III/IIIB) were strongly associated with higher procedural mortality and major adverse cardiac events.
  • Covered stent use was associated with a significantly increased risk of stent thrombosis at 2.9-year follow-up (9.1% vs. 0.9%).

Conclusions:

  • Coronary perforation incidence rose between 2001 and 2019, highlighting a need for improved prevention and management strategies.
  • Severe perforations are independent predictors of long-term mortality and adverse cardiac events.
  • While effective for acute management, early-generation covered stents carry a substantial risk of late stent thrombosis, necessitating further device development.

Related Concept Videos

Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
131
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
158